Trade Truce Hope: How US-China Talks Could Boost Healthcare ETFs
Hopes of a U.S.-China trade truce are lifting sentiment for healthcare ETFs like XLV, IYH, and VHT, which could gain from easing tariffs and lower costs.
Zacks·1d ago
More News
Trump Steps Up Pressure On Trading Partners Over Drug Costs, Plans Section 301 Review: Report
Stocktwits·4d ago
ETFs to Watch Post JNJ's Q3 Earnings Surprise & Bullish Outlook
JNJ's Q3 earnings beat and raised 2025 sales outlook could lift healthcare ETFs like IHE, XLV and IYH, heavily weighted toward the drugmaker.
Zacks·9d ago
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
As AI-fueled markets show bubble risks, defensive ETFs like XLP, XLU, and XLV offer investors stability and downside protection.
Zacks·15d ago
If the AI Bubble Bursts, Here Are Some Defensive ETFs to Consider
As AI-fueled gains spark bubble warnings, investors are eyeing defensive ETFs in consumer staples, utilities and healthcare for safety.
Zacks·16d ago
Trump Walks Back Plan To Slap Tariffs On Generic Drugs After White House Clash Over Prices, Supply Risks: Report
The administration is now exploring alternative measures, such as federal grants or loans, to encourage the domestic production of critical generic drugs, aiming to reduce reliance on foreign suppliers, including India.
Stocktwits·17d ago
Why Is This the Best Time to Bet on Consumer Staples ETFs?
As the U.S. government shutdown deepens economic uncertainty, investors may turn to consumer staples ETFs like XLP, FTXG and PBJ for stability.
Zacks·17d ago
US Government Shutdown Puts These ETFs in Focus
The U.S. government shut down on Oct. 1, 2025, as last-minute talks failed. ETFs like TLT, XLV and PSCC hog attention.
Zacks·23d ago
White House Clarifies Recent Pharmaceutical Tariffs Exempt Countries with Trade Agreements: Report
According to a Reuters report cited by TradingView, a White House official stated that the Trump administration will honor the 15% pharmaceutical tariff cap for trade partners such as the EU and Japan, as outlined in existing agreements.